{"id":"https://openalex.org/W2889521172","doi":"https://doi.org/10.1002/dmrr.3070","title":"Glucagon\u2010like peptide\u20101 receptor agonists in type 2 diabetes treatment: are they all the same?","display_name":"Glucagon\u2010like peptide\u20101 receptor agonists in type 2 diabetes treatment: are they all the same?","publication_year":2018,"publication_date":"2018-08-30","ids":{"openalex":"https://openalex.org/W2889521172","doi":"https://doi.org/10.1002/dmrr.3070","mag":"2889521172","pmid":"https://pubmed.ncbi.nlm.nih.gov/30156747"},"language":"en","primary_location":{"id":"doi:10.1002/dmrr.3070","doi":"https://doi.org/10.1002/dmrr.3070","is_oa":false,"landing_page_url":"https://doi.org/10.1002/dmrr.3070","pdf_url":null,"source":{"id":"https://openalex.org/S83251063","display_name":"Diabetes/Metabolism Research and Reviews","issn_l":"1520-7552","issn":["1520-7552","1520-7560"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes/Metabolism Research and Reviews","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060140104","display_name":"Raffaella Gentilella","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210164813","display_name":"Eli Lilly (Italy)","ror":"https://ror.org/05d0e9y67","country_code":"IT","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210164813"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Raffaella Gentilella","raw_affiliation_strings":["Eli Lilly Italia, Sesto Fiorentino, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly Italia, Sesto Fiorentino, Italy","institution_ids":["https://openalex.org/I4210164813"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089497324","display_name":"Valeria Pechtner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Valeria Pechtner","raw_affiliation_strings":["Lilly Diabetes, Eli Lilly and Company, Neuilly-sur-Seine, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Diabetes, Eli Lilly and Company, Neuilly-sur-Seine, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005241900","display_name":"Antonella Corcos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210164813","display_name":"Eli Lilly (Italy)","ror":"https://ror.org/05d0e9y67","country_code":"IT","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210164813"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Antonella Corcos","raw_affiliation_strings":["Eli Lilly Italia, Sesto Fiorentino, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly Italia, Sesto Fiorentino, Italy","institution_ids":["https://openalex.org/I4210164813"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5003186286","display_name":"Agostino Consoli","orcid":"https://orcid.org/0000-0002-1885-451X","observed_orcids":["https://orcid.org/0000-0002-1885-451X"]},"institutions":[{"id":"https://openalex.org/I39387349","display_name":"University of Chieti-Pescara","ror":"https://ror.org/00qjgza05","country_code":"IT","type":"education","lineage":["https://openalex.org/I39387349"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Agostino Consoli","raw_affiliation_strings":["Department of Medicine and Ageing Sciences and CeSI-Met, University D'Annunzio, Chieti, Italy"],"raw_orcid":"https://orcid.org/0000-0002-1885-451X","affiliations":[{"raw_affiliation_string":"Department of Medicine and Ageing Sciences and CeSI-Met, University D'Annunzio, Chieti, Italy","institution_ids":["https://openalex.org/I39387349"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5003186286"],"corresponding_institution_ids":["https://openalex.org/I39387349"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":3.5854,"has_fulltext":false,"cited_by_count":238,"citation_normalized_percentile":{"value":0.96412387,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"35","issue":"1","first_page":"e3070","last_page":"e3070"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9570000171661377},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9359999895095825},{"id":"https://openalex.org/keywords/exenatide","display_name":"exenatide","score":0.9350000023841858},{"id":"https://openalex.org/keywords/lixisenatide","display_name":"lixisenatide","score":0.9129999876022339},{"id":"https://openalex.org/keywords/albiglutide","display_name":"albiglutide","score":0.8949999809265137},{"id":"https://openalex.org/keywords/dulaglutide","display_name":"dulaglutide","score":1.0},{"id":"https://openalex.org/keywords/liraglutide","display_name":"liraglutide","score":0.9010000228881836},{"id":"https://openalex.org/keywords/semaglutide","display_name":"semaglutide","score":0.996999979019165},{"id":"https://openalex.org/keywords/exendin-4","display_name":"exendin-4","score":0.7749999761581421},{"id":"https://openalex.org/keywords/gastric-emptying","display_name":"gastric emptying","score":0.7749999761581421},{"id":"https://openalex.org/keywords/glucose-dependent-insulin-secretion","display_name":"glucose-dependent insulin secretion","score":0.9070000052452087},{"id":"https://openalex.org/keywords/glucagon-secretion","display_name":"glucagon secretion","score":0.8859999775886536},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.8199999928474426},{"id":"https://openalex.org/keywords/immunogenicity","display_name":"immunogenicity","score":0.8379999995231628},{"id":"https://openalex.org/keywords/gastrointestinal-tolerability","display_name":"gastrointestinal tolerance","score":0.7459999918937683},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.6240000128746033},{"id":"https://openalex.org/keywords/drug-administration-routes","display_name":"drug administration routes","score":0.414000004529953}],"concepts":[{"id":"https://openalex.org/C2776398474","wikidata":"https://www.wikidata.org/wiki/Q424611","display_name":"Glucagon-like peptide-1","level":4,"score":0.6102298498153687},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5725752711296082},{"id":"https://openalex.org/C185280430","wikidata":"https://www.wikidata.org/wiki/Q14909910","display_name":"Glucagon-like peptide 1 receptor","level":4,"score":0.5597084164619446},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5420902371406555},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4978799819946289},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4702267348766327},{"id":"https://openalex.org/C2781232474","wikidata":"https://www.wikidata.org/wiki/Q124407","display_name":"Type 1 diabetes","level":3,"score":0.46752193570137024},{"id":"https://openalex.org/C2779281246","wikidata":"https://www.wikidata.org/wiki/Q172847","display_name":"Peptide","level":2,"score":0.4494450092315674},{"id":"https://openalex.org/C2778563252","wikidata":"https://www.wikidata.org/wiki/Q170617","display_name":"Glucagon","level":3,"score":0.4477435052394867},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4289966821670532},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.41000333428382874},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.3766406178474426},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.369608998298645},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3690641224384308},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.2529918849468231},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1736769676208496}],"mesh":[{"descriptor_ui":"D000077270","descriptor_name":"Exenatide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000097789","descriptor_name":"Glucagon-Like Peptide-1 Receptor Agonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004763","descriptor_name":"Glucagon-Like Peptides","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D004763","descriptor_name":"Glucagon-Like Peptides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007141","descriptor_name":"Immunoglobulin Fc Fragments","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/dmrr.3070","doi":"https://doi.org/10.1002/dmrr.3070","is_oa":false,"landing_page_url":"https://doi.org/10.1002/dmrr.3070","pdf_url":null,"source":{"id":"https://openalex.org/S83251063","display_name":"Diabetes/Metabolism Research and Reviews","issn_l":"1520-7552","issn":["1520-7552","1520-7560"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes/Metabolism Research and Reviews","raw_type":"journal-article"},{"id":"pmid:30156747","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30156747","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes/metabolism research and reviews","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":130,"referenced_works":["https://openalex.org/W906438903","https://openalex.org/W1482710124","https://openalex.org/W1559082056","https://openalex.org/W1584571461","https://openalex.org/W1701595965","https://openalex.org/W1854533075","https://openalex.org/W1923756566","https://openalex.org/W1945841307","https://openalex.org/W1951367122","https://openalex.org/W1966379378","https://openalex.org/W1970905724","https://openalex.org/W1972057139","https://openalex.org/W1972187673","https://openalex.org/W1975929001","https://openalex.org/W1977102586","https://openalex.org/W1980053049","https://openalex.org/W1982991923","https://openalex.org/W1984740259","https://openalex.org/W1985743763","https://openalex.org/W1986085856","https://openalex.org/W1992055007","https://openalex.org/W1995999856","https://openalex.org/W1998281835","https://openalex.org/W2002057113","https://openalex.org/W2002757015","https://openalex.org/W2003415509","https://openalex.org/W2003589032","https://openalex.org/W2004409542","https://openalex.org/W2005088542","https://openalex.org/W2009288620","https://openalex.org/W2014156217","https://openalex.org/W2019513002","https://openalex.org/W2023695436","https://openalex.org/W2028272916","https://openalex.org/W2028371970","https://openalex.org/W2030546890","https://openalex.org/W2041522924","https://openalex.org/W2043900831","https://openalex.org/W2045188930","https://openalex.org/W2050826565","https://openalex.org/W2054981500","https://openalex.org/W2058239977","https://openalex.org/W2058922633","https://openalex.org/W2061883499","https://openalex.org/W2062098402","https://openalex.org/W2070710390","https://openalex.org/W2071223663","https://openalex.org/W2071835038","https://openalex.org/W2072239150","https://openalex.org/W2072691447","https://openalex.org/W2073295531","https://openalex.org/W2077751509","https://openalex.org/W2078839892","https://openalex.org/W2087707716","https://openalex.org/W2096416969","https://openalex.org/W2098459806","https://openalex.org/W2099352903","https://openalex.org/W2104252114","https://openalex.org/W2105812875","https://openalex.org/W2106049537","https://openalex.org/W2106709036","https://openalex.org/W2107949845","https://openalex.org/W2108122035","https://openalex.org/W2112981414","https://openalex.org/W2113367996","https://openalex.org/W2114027444","https://openalex.org/W2114542756","https://openalex.org/W2116286254","https://openalex.org/W2119355349","https://openalex.org/W2127509345","https://openalex.org/W2128034652","https://openalex.org/W2128825255","https://openalex.org/W2129377335","https://openalex.org/W2129934471","https://openalex.org/W2133648480","https://openalex.org/W2135064706","https://openalex.org/W2136259411","https://openalex.org/W2137352234","https://openalex.org/W2137562839","https://openalex.org/W2138077952","https://openalex.org/W2138290933","https://openalex.org/W2139485303","https://openalex.org/W2139772567","https://openalex.org/W2140682563","https://openalex.org/W2152984355","https://openalex.org/W2154433510","https://openalex.org/W2158778171","https://openalex.org/W2160001758","https://openalex.org/W2160088494","https://openalex.org/W2160274347","https://openalex.org/W2162001095","https://openalex.org/W2162934281","https://openalex.org/W2163229244","https://openalex.org/W2165556241","https://openalex.org/W2170606300","https://openalex.org/W2171857877","https://openalex.org/W2174832318","https://openalex.org/W2178377864","https://openalex.org/W2185293568","https://openalex.org/W2193664952","https://openalex.org/W2199333711","https://openalex.org/W2210133271","https://openalex.org/W2261901121","https://openalex.org/W2270869067","https://openalex.org/W2282578582","https://openalex.org/W2282876332","https://openalex.org/W2335878298","https://openalex.org/W2414005931","https://openalex.org/W2425644022","https://openalex.org/W2486351957","https://openalex.org/W2519510391","https://openalex.org/W2524961794","https://openalex.org/W2527920149","https://openalex.org/W2530717584","https://openalex.org/W2560388718","https://openalex.org/W2572398654","https://openalex.org/W2586129535","https://openalex.org/W2602700371","https://openalex.org/W2604469807","https://openalex.org/W2695892839","https://openalex.org/W2754041380","https://openalex.org/W2768268612","https://openalex.org/W2773969925","https://openalex.org/W2774157762","https://openalex.org/W2787255324","https://openalex.org/W2791793704","https://openalex.org/W2806366828","https://openalex.org/W2808008353","https://openalex.org/W2916996193","https://openalex.org/W4230892627"],"related_works":["https://openalex.org/W1695457816","https://openalex.org/W7099425336","https://openalex.org/W1885494502","https://openalex.org/W2123041020","https://openalex.org/W2196942236","https://openalex.org/W2808414723","https://openalex.org/W2049798496","https://openalex.org/W2765093610","https://openalex.org/W3093042356","https://openalex.org/W4413112348"],"abstract_inverted_index":{"Glucagon-like":[0],"peptide-1":[1],"(GLP-1)":[2],"receptor":[3],"agonists":[4],"(RAs)":[5],"are":[6,30],"an":[7,91],"important":[8,92],"class":[9,29],"of":[10,44,55,96,107,203,208],"drugs":[11,52],"with":[12,21],"a":[13],"well-established":[14],"efficacy":[15,133],"and":[16,65,71,105,124,134,147,149,158,173,185,193,201,223,233,243,250],"safety":[17,135],"profile":[18],"in":[19,27,38,53,189,215],"patients":[20],"type":[22],"2":[23],"diabetes":[24],"mellitus.":[25],"Agents":[26],"this":[28,97],"derived":[31],"from":[32],"either":[33],"exendin-4":[34],"(a":[35],"compound":[36],"present":[37],"Gila":[39],"monster":[40],"venom)":[41],"or":[42],"modifications":[43],"human":[45],"GLP-1":[46,108,126,160,210],"active":[47],"fragment.":[48],"Differences":[49],"among":[50],"these":[51],"duration":[54],"action":[56],"(ie,":[57,143,151],"short-acting":[58,123,142,164],"vs":[59],"long-acting),":[60],"effects":[61],"on":[62,117,130],"glycaemic":[63],"control":[64],"weight":[66],"loss,":[67],"immunogenicity,":[68],"tolerability":[69,221],"profiles,":[70,222],"administration":[72,227],"routes":[73],"offer":[74],"physicians":[75],"several":[76],"options":[77],"when":[78],"selecting":[79],"the":[80,102,118,121,190,239],"most":[81],"appropriate":[82],"agent":[83],"for":[84,112,231,236],"individual":[85,132],"patients.":[86],"Patient":[87],"preference":[88],"is":[89,99,162],"also":[90],"consideration.":[93],"The":[94,137],"aim":[95],"review":[98],"to":[100],"discuss":[101],"differences":[103],"between":[104,141],"similarities":[106],"RAs":[109,127,161,211],"currently":[110],"approved":[111],"clinical":[113],"use,":[114],"focusing":[115],"particularly":[116],"properties":[119],"characterising":[120],"single":[122],"long-acting":[125,150,174,209,240],"rather":[128],"than":[129],"their":[131],"profiles.":[136],"primary":[138],"pharmacodynamic":[139],"difference":[140],"exenatide":[144,154,241],"twice":[145],"daily":[146,230],"lixisenatide)":[148],"albiglutide,":[152,237],"dulaglutide,":[153,238],"once":[155,234],"weekly,":[156],"liraglutide,":[157],"semaglutide)":[159],"that":[163],"agents":[165,175],"primarily":[166],"delay":[167],"gastric":[168],"emptying":[169],"(lowering":[170],"postprandial":[171,194,198],"glucose)":[172],"affect":[176],"both":[177],"fasting":[178,191],"glucose":[179,195],"(via":[180,196],"enhanced":[181,197],"glucose-dependent":[182],"insulin":[183,199],"secretion":[184,188,200],"reduced":[186],"glucagon":[187,204],"state)":[192],"inhibition":[202],"secretion).":[205],"Other":[206],"advantages":[207],"include":[212],"smaller":[213],"fluctuations":[214],"plasma":[216],"drug":[217],"concentrations,":[218],"improved":[219],"gastrointestinal":[220],"simpler,":[224],"more":[225],"convenient":[226],"schedules":[228],"(once":[229],"liraglutide":[232],"weekly":[235],"formulation,":[242],"semaglutide),":[244],"which":[245],"might":[246],"improve":[247],"treatment":[248],"adherence":[249],"persistence.":[251]},"counts_by_year":[{"year":2026,"cited_by_count":26},{"year":2025,"cited_by_count":18},{"year":2024,"cited_by_count":33},{"year":2023,"cited_by_count":30},{"year":2022,"cited_by_count":27},{"year":2021,"cited_by_count":42},{"year":2020,"cited_by_count":38},{"year":2019,"cited_by_count":22},{"year":2018,"cited_by_count":2}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2018-09-07T00:00:00"}